Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)
Clinical trial NCT03852433 · COMPLETED
Trial details
- NCT number
- NCT03852433
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2022-04-05
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.